Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 68Breast Neoplasms 58Carcinoma, Non-Small-Cell Lung 36Triple Negative Breast Neoplasms 28Squamous Cell Carcinoma of Head and Neck 15Neoplasms 11Head and Neck Neoplasms 11Lung Neoplasms 10Esophageal Squamous Cell Carcinoma 10Neoplasm Metastasis 7Stomach Neoplasms 6Melanoma 6Adenocarcinoma 6Esophageal Neoplasms 5Cholangiocarcinoma 5Advanced Pancreatic Cancer 5Inflammatory Breast Neoplasms 4Gallbladder Neoplasms 4Fallopian Tube Neoplasms 4Carcinoma 4Small Cell Lung Carcinoma 3Recurrence 3Pathologic Complete Response 3Ovarian Neoplasms 3Neoplasms by Site 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Carcinoma, Squamous Cell 3Uveal Melanoma 2Uterine Cervical Neoplasms 2

Interventions

Gemcitabine 7Albumin-Bound Paclitaxel 5Taxes 4Fluorouracil 4dehydroftorafur 3Radiotherapy 3Oxaliplatin 3Radiotherapy, Intensity-Modulated 2Losartan 2Leucovorin 2Irinotecan 2130-nm albumin-bound paclitaxel 2irinotecan sucrosofate 1indusatumab 1X-Rays 1Surgical Procedures, Operative 1Specimen Handling 1S 1 (combination) 1Radiotherapy, Image-Guided 1Radiation 1Pancreatectomy 1Folfox protocol 1Erlotinib Hydrochloride 1Cetuximab 1Capecitabine 1Anesthesia, General 1Anesthesia 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Pancreatic Adenocarcinoma × 130-nm albumin-bound paclitaxel × Clear all
NCT02427841 2023-09-06

Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

OHSU Knight Cancer Institute

Phase 2 Completed
20 enrolled 17 charts
Gastrointestinal

Pancreatic Adenocarcinoma

NCT02562716 2022-10-19

S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

SWOG Cancer Research Network

Phase 2 Completed
147 enrolled 16 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡